Bausch Health Companies Inc. has announced the final results and expiration of its previously announced offers to exchange its outstanding 4.875% Senior Secured Notes due 2028 and 11.00% Senior Secured Notes due 2028. The exchange offers aimed to issue up to $1.6 billion aggregate principal amount of new 10.00% Senior ...

BioNexus Gene Lab Corp. is evaluating a potential expansion into Contract Development and Manufacturing (CDMO) activities through its subsidiary, Chemrex Corporation Sdn. Bhd. This evaluation is part of a broader business rationalization initiative due to challenges in Chemrex's legacy operations and the company's stra...

Bloom Energy Corporation entered into a Credit Agreement on December 19, 2025, establishing a $600 million senior secured multicurrency revolving credit facility. This facility allows for borrowings in various currencies including USD, British pounds sterling, euros, Japanese yen, and Singapore dollars, to be used for ...

On December 18, 2025, Bluerock Homes Trust, Inc. announced the completion of an acquisition through its subsidiary, BHM Parkview Exchange TRS, LLC. The company, via its operating partnership Bluerock Residential Holdings, L.P., invested approximately $21.3 million in BHM Parkview Investment Co, LLC. An affiliate of the...

Braemar Hotels & Resorts Inc. (the "Company") and its operating subsidiary, Braemar Hospitality Limited Partnership, entered into an Amendment to a letter agreement dated August 26, 2025. This amendment clarifies the terms under which termination fees are due and payable to the Advisor (Ashford Inc. and Ashford Hospita...

Bridgeline Digital, Inc. reported its financial results for the fourth quarter of fiscal year 2025, ending September 30, 2025. The company announced total revenue of $3.9 million, with subscription revenue at $3.1 million (an increase of 4% year-over-year) and services revenue at $0.7 million. For the full fiscal year ...

Burke & Herbert Financial Services Corp. (the "Company") announced that its wholly-owned subsidiary, Burke & Herbert Bank & Trust Company (the "Bank"), entered into the First Amendment to the Summit Community Bank Supplemental Executive Retirement Plan and Consent to Termination of Summit Community Bank Supplemental Ex...

On December 22, 2025, Calavo Growers, Inc. received a letter from the U.S. Securities and Exchange Commission (SEC) staff. The staff concluded their investigation related to the Company and stated that they do not intend to recommend an enforcement action against Calavo Growers, Inc. This notice was provided under the ...

Cassava Sciences, Inc. has reached a settlement in a consolidated securities class action lawsuit. The lawsuit, filed in the U.S. District Court for the Western District of Texas, alleged violations of federal securities laws. The settlement, agreed upon through mediation, involves the company paying $31.25 million to ...

CDW LLC, a subsidiary of CDW Corporation, has entered into a new five-year senior unsecured credit facility totaling $2,884.5 million. This facility includes a $634.5 million term loan and a $2,250.0 million revolving loan, with subfacilities for letters of credit and swingline loans. The new facility consolidates and ...

Cemtrex Inc. has entered into a Securities Purchase Agreement with an accredited institutional investor for a registered direct offering. The offering aims to raise aggregate gross proceeds of $2,000,000 through the issuance of common stock and/or pre-funded warrants. The transaction closed on December 23, 2025, with t...

On December 22, 2025, China Pharma Holdings, Inc. (the "Company"), through its wholly owned subsidiary Hainan Helpson Medical & Biotechnology Co., Ltd ("Helpson"), entered into a Technology Transfer Agreement with Juan Zhang. The agreement involves the transfer of an invention patent for Ipragliflozin tablets and its p...

Citius Oncology, Inc. announced its financial results for the fiscal year ended September 30, 2025, and provided a business update. The company reported a net loss of $24.8 million for FY2025, compared to $21.1 million in FY2024. Research and development expenses increased to $6.4 million from $4.9 million, and general...

On December 16, 2025, Coffee Holding Co., Inc. held its Annual Meeting of Stockholders. A quorum was present, with approximately 53.9% of the common stock outstanding and entitled to vote in attendance. Key matters voted on included the election of directors, ratification of the appointment of CBIZ CPAs P.C. as indepen...

Comcast Corporation has entered into a new employment agreement with Michael J. Cavanagh, effective December 19, 2025, in anticipation of his appointment as Co-Chief Executive Officer on January 2, 2026. The agreement secures his employment through January 1, 2029. Mr. Cavanagh will receive an annual base salary of $2,...

Compass Minerals International, Inc. has reported the preliminary approval of a settlement for stockholder derivative actions. The lawsuits, Morelli v. Crutchfield et al. and Assad v. Crutchfield et al., alleged breaches of fiduciary duties by current and former directors and officers. The settlement requires the compa...

The Cooper Companies, Inc. has entered into a cooperation agreement with Browning West, LP. As part of this agreement, Walter M. Rosebrough, Jr. will be appointed to the Company's Board of Directors and its Corporate Governance and Nominating Committee, effective January 3, 2026. The Company has also agreed to nominate...

CVB Financial Corp. and Heritage Commerce Corp have entered into an Agreement and Plan of Reorganization and Merger. Heritage Commerce Corp will merge with and into CVB Financial Corp., with CVB Financial Corp. continuing as the surviving corporation. Subsequently, Heritage Bank of Commerce will merge with and into Cit...

Cadrenal Therapeutics, Inc. has filed a prospectus supplement with the SEC for its at-the-market (ATM) offering program. The company intends to offer and sell up to $1,770,028 of its common stock through H.C. Wainwright & Co., LLC as the sales agent. This offering is made under an existing ATM Agreement and is pursuant...

CAMP4 Therapeutics Corporation (the "Company") entered into a Lease Amendment with ARE-MA Region No. 59, LLC ("ARE 59") to amend their existing Cambridge Lease. The amendment accelerates the termination date of the Cambridge Lease to thirty days after the Commencement Date of a new Watertown Lease. Base rent for the Ca...

Cayson Acquisition Corp. (the SPAC) entered into a loan agreement with Mango Financial Limited for $600,000. This loan, evidenced by a promissory note, will be deposited into the SPAC's trust account to extend the deadline for consummating an initial business combination from December 23, 2025, to March 23, 2026. The l...

Celularity Inc. has entered into material definitive agreements related to senior secured note financing and convertible note financing with an accredited investor. The company issued a $7,000,000 senior secured note and a warrant to purchase 2,448,917 shares of Class A common stock. The senior note accrues 4% annual i...

Centuri Holdings, Inc. announced that James W. Connell, Jr., Executive Vice President, Chief Commercial and Strategy Officer, has decided to resign from his position. His resignation will be effective January 31, 2026. The company stated that Mr. Connell's decision was a personal one, driven by his desire to pursue a n...

On December 18, 2025, Churchill Capital Corp XI (the "Company") consummated its initial public offering (IPO) of 41,400,000 units, generating gross proceeds of $414,000,000. Each unit, priced at $10.00, consists of one Class A ordinary share and one-tenth of a redeemable warrant. Simultaneously, the Company completed a...

Citius Pharmaceuticals, Inc. reported its business and financial results for the fiscal year ended September 30, 2025. A key highlight was the December 2025 launch of LYMPHIR™ by its subsidiary, Citius Oncology, for the treatment of certain types of cutaneous T-cell lymphoma (CTCL). The company also reported advancemen...